Published in Vaccine Weekly, May 24th, 2000
"The skin is well-suited to serve as a substrate for vaccination strategies," stated R.D. Granstein and colleagues, Cornell University, New York. "In this regard, epidermal cells exposed to granulocyte-macrophage colony-stimulating factor can, upon subcutaneous injection into naive mice, present a soluble extract of tumor as a source of tumor-associated antigens for the induction of in vivo anti-tumor immunity. Use of RNA for immunization has a potential advantage over this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly